Meibomian Gland Dysfunction Treatment

Completed · Not applicable · Has a placebo group

Conditions studied: Meibomian Gland Dysfunction, Dry Eye

In brief

The purpose of this study is to evaluate the effectiveness of treatments for Meibomian Gland Dysfunction.

Key facts

Study ID

NCT04229888

Run by

Indiana University

People needed

14

Starts

2020-02-26

Expected to finish

2021-03-25

Last updated by the study team

2022-03-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• evidence of meibomian gland obstruction in both eyes
• dry eye symptoms per DEQ-5

You may not qualify if…

• active ocular infection
• previous LipiFlow treatment
• beginning new oral or other systemic medications within prior 3 months
• beginning new or changing dosages of ocular medications within prior 3 months
• previous ocular surgery, trauma, herpes, recurrent inflammation, punctal plugs in prior 3 months
• habitual contact lens wear in prior 3 months
• women who are pregnant or nursing

Where it is running

• Indiana University School of Optometry — Bloomington, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.